Physician profile
Dana Robert Desser
NPI 1073714333
$6,176.52
in general payments reported to CMS, 2019-2025
23 companies · $1,085 in 2025
The $1,085 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,296 · 2020: $164 · 2021: $261 · 2022: $288 · 2023: $860 · 2024: $223 · 2025: $1,085.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $1,001 · Travel and Lodging: $642 · Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $1,000.61 |
| Travel and Lodging | $642.30 |
| Food and Beverage | $525.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $3,117.57 | 2019-2022 | |
| Integra Lifesciences Corporation | $1,000.61 | 2025 | Cytal, Micromatrix |
| Ortho Development Corporation | $684.80 | 2023 | |
| Depuy Synthes Sales INC. | $530.93 | 2020-2024 | Orthovisc, Monovisc |
| Horizon Therapeutics Plc | $302.64 | 2019-2022 | |
| Kyocera Medical Technologies, INC. | $74.30 | 2020 | |
| Stryker Corporation | $54.32 | 2019 | |
| Aesculap Implant Systems, LLC | $47.63 | 2019 | |
| Fidia Pharma USA INC. | $42.06 | 2019 | |
| Boston Scientific Corporation | $38.54 | 2021-2023 | |
| Amgen INC. | $37.22 | 2022-2023 | Prolia, Evenity |
| Orthalign INC | $36.28 | 2025 | Orthalign Plus |
| Vertex Pharmaceuticals Incorporated | $31.90 | 2025 | |
| Molnlycke Health Care US, LLC | $25.03 | 2024 | Mepilex Border Post-Op Ag, Avance |
| Vericel Corporation | $21.96 | 2024 | Maci |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $21.40 | 2019 | |
| Daiichi Sankyo INC. | $20.79 | 2019 | |
| Mimedx Group, INC. | $16.40 | 2025 | |
| Heraeus Medical, LLC. | $16.37 | 2021 | |
| Collegium Pharmaceutical, INC. | $16.09 | 2021 | |
| Bioventus LLC | $15.36 | 2024 | Gelsyn-3 |
| Smith+Nephew, INC. | $13.63 | 2019 | |
| Dynasplint Systems INC. | $10.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Desser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.